Adherence to the European Society of Cardiology guidelines for the treatment of chronic heart failure

1st International Conference on Tropical Medicine and Infectious Diseases (ICTROMI) Faculty of Medicine Universitas Sumatera Utara

Sitepu, A.^1,2 ; Hamdani, K.^3

Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia^1

Haji Adam Malik General Hospital, Medan, Indonesia^2

Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia^3

关键词: Angiotensin converting enzyme inhibitors;    Chronic heart failures;    Co morbidities;    Ejection fraction;    Guideline adherence;    Mineralocorticoid receptors;    Observational study;    Successful management;   

Others  :  https://iopscience.iop.org/article/10.1088/1755-1315/125/1/012117/pdf
DOI  :  10.1088/1755-1315/125/1/012117

来源: IOP

【 摘 要 】

Heart failure is a tremendous health problem with significant morbidity and mortality. The treatment of heart failure should be applied appropriately to improve the successful management of patients. This study aims to evaluate the adherence to European Society of Cardiology (ESC) guidelines for the treatment of chronic heart failure and to determine factors associated with guideline adherence. This study is an observational study comprising 97 patients with chronic heart failure with reduced ejection fraction. The guideline adherence was assessed the by the use of guideline adherence indicator (GAI), which consider GAI-3 or GAI-5, by calculating the proportion of recommended drugs was prescribed divided by a number of drugs indicated according to the ESC guidelines, in the absence of contraindications. The results showed the use of each indicated drugs were angiotensin- converting enzyme inhibitors or angiotensin receptor blockers (78.4%), beta-blockers (61.9%), mineralocorticoid receptor antagonists (61.9%), diuretics (89.7%), and digitalis (26.8%). Furthermore, the predominant categories of GAI-3 and GAI-5 were moderate. This study demonstrates that the adherence to ESC guidelines for the treatment of chronic heart failure still needs to be improved compared to recent studies. Also, age, etiology of heart failure and comorbidity were associated factors that influence the implementation of ESC guidelines.